| International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy MP Abbracchio, G Burnstock, JM Boeynaems, EA Barnard, JL Boyer, ... Pharmacological reviews 58 (3), 281-341, 2006 | 1578 | 2006 |
| Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family MP Abbracchio, JM Boeynaems, EA Barnard, JL Boyer, C Kennedy, ... Trends in pharmacological sciences 24 (2), 52-55, 2003 | 563 | 2003 |
| Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase D Communi, C Govaerts, M Parmentier, JM Boeynaems Journal of Biological Chemistry 272 (51), 31969-31973, 1997 | 454 | 1997 |
| Identification of a novel human ADP receptor coupled to Gi D Communi, NS Gonzalez, M Detheux, S Brézillon, V Lannoy, ... Journal of Biological Chemistry 276 (44), 41479-41485, 2001 | 420 | 2001 |
| Cloning, functional expression and tissue distribution of the human P2Y6Receptor D Communi, M Parmentier, JM Boeynaems Biochemical and biophysical research communications 222 (2), 303-308, 1996 | 364 | 1996 |
| Pharmacological characterization of the human P2Y11 receptor D Communi, B Robaye, JM Boeynaems British journal of pharmacology 128 (6), 1199-1206, 1999 | 340 | 1999 |
| Cloning and Functional Expression of a Human Uridine Nucleotide Receptor (∗) D Communi, S Pirotton, M Parmentier, JM Boeynaems Journal of Biological Chemistry 270 (52), 30849-30852, 1995 | 327 | 1995 |
| Purinergic signalling and immune cells G Burnstock, JM Boeynaems Purinergic signalling 10 (4), 529-564, 2014 | 326 | 2014 |
| Pharmacological characterization of the human P2Y13 receptor F Marteau, E Le Poul, D Communi, D Communi, C Labouret, P Savi, ... Molecular pharmacology 64 (1), 104-112, 2003 | 277 | 2003 |
| The P2Y11 receptor mediates the ATP-induced maturation of human monocyte-derived dendritic cells F Wilkin, X Duhant, C Bruyns, N Suarez-Huerta, JM Boeynaems, ... The Journal of Immunology 166 (12), 7172-7177, 2001 | 240 | 2001 |
| Involvement of inositol 1, 4, 5-trisphosphate and calcium in the action of adenine nucleotides on aortic endothelial cells. S Pirotton, E Raspé, D Demolle, C Erneux, JM Boeynaems Journal of Biological Chemistry 262 (36), 17461-17466, 1987 | 240 | 1987 |
| Quantitative analysis of the binding of ligands to their receptors JM Boeynaems, JE Dumont Journal of cyclic nucleotide research 1 (3), 123-142, 1975 | 235 | 1975 |
| Pharmacological characterization of the human P2Y4 receptor D Communi, S Motte, JM Boeynaems, S Pirotton European journal of pharmacology 317 (2-3), 383-389, 1996 | 223 | 1996 |
| Advances in signalling by extracellular nucleotides: the role and transduction mechanisms of P2Y receptors D Communi, R Janssens, N Suarez-Huerta, B Robaye, JM Boeynaems Cellular signalling 12 (6), 351-360, 2000 | 214 | 2000 |
| Outlines of receptor theory JM Boeynaems, JE Dumont | 202 | 1980 |
| P2 purinoceptors on vascular endotheliai cells: physiological significance and transduction mechanisms JM Boeynaems, JD Pearson Trends in pharmacological sciences 11 (1), 34-37, 1990 | 201 | 1990 |
| The purinergic receptor P2Y2 receptor mediates chemotaxis of dendritic cells and eosinophils in allergic lung inflammation T Müller, B Robaye, RP Vieira, D Ferrari, M Grimm, T Jakob, SF Martin, ... Allergy 65 (12), 1545-1553, 2010 | 188 | 2010 |
| P2Y nucleotide receptors: promise of therapeutic applications KA Jacobson, JM Boeynaems Drug discovery today 15 (13-14), 570-578, 2010 | 184 | 2010 |
| Preparation and assay of monohydroxy-eicosatetraenoic acids JM Boeynaems, AR Brash, JA Oates, WC Hubbard Analytical biochemistry 104 (2), 259-267, 1980 | 184 | 1980 |
| The nucleotide receptor P2Y13 is a key regulator of hepatic High-Density Lipoprotein (HDL) endocytosis S Jacquet, C Malaval, LO Martinez, K Sak, C Rolland, C Perez, M Nauze, ... Cellular and Molecular Life Sciences CMLS 62, 2508-2515, 2005 | 167 | 2005 |
